It was approved by the National Health Surveillance Agency (Anvisa), the registration of a new vaccine against dengue. The immunizer called Qdenga, produced by the company Takeda Pharma, is indicated for people between 4 and 60 years old. The new vaccine is composed of four different serotypes of the virus disease-causing. This ensures ample protection against the disease. Learn more throughout the article.
see more
How to get your CNH for free in 2023?
After hacker attacks, Microsoft releases free tools for…
Dengue is a viral disease transmitted by the bite of an infected Aedes aegypti mosquito. It is most common in tropical and subtropical areas of the world, including many parts of North, Central and South America, as well as parts of Asia and Africa. Africa.
Dengue symptoms usually appear 4 to 10 days after infection and may include high fever, pain headache, eye pain, muscle and joint pain, nausea, vomiting, skin rashes and pain abdominal.
In severe cases, dengue can lead to dengue hemorrhagic fever, a more severe form of the disease that can be fatal.
The National Technical Commission on Biosafety (CTNBio) approved the safety of the Qdenga vaccine, which was awaiting approval from Anvisa. There is already another dengue vaccine approved in the country, Dengvaxia. However, it can only be applied by those who have already had the disease.
The application will be subcutaneous, applied in two doses, with an interval of three months between applications.
Brazil even recorded more than a thousand deaths from complications of dengue in the country last year.
The Qdenga vaccine has also been evaluated by the European health agency (EMA), the body that provided the approval. The immunizer will remain subject to the monitoring of adverse events through pharmacovigilance actions under the responsibility of the company itself.
A Anvisa plays a key role in the regulation and approval of vaccines in Brazil. The agency is responsible for evaluating the quality, efficacy and safety of vaccines, ensuring that they meet all necessary requirements before they are made available for public use.
Lover of movies and series and everything that involves cinema. An active curious on the networks, always connected to information about the web.